Highlights
AMEX: SYN       Synthetic Biologics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.912   +0.044 (5.07%)  0.85 - 0.951  22,870,600

Overview

 
Avg Volume (4 weeks):36,699,644
4 Weeks Range:0.356 - 1.70
4 Weeks Price Volatility (%):
41.37%
52 Weeks Range:0.252 - 1.70
52 Weeks Price Volatility (%):
45.58%
Average Price Target: 3.00
Price Target Upside/Downside: +2.088

Headlines



No recent Headlines for this stock.


Business Background

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery-stage biotherapeutics for the treatment of phenylketonuria.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

6239  2800  512  101 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00